The deal is worth up to $658m in total, since Lundbeck initially will pay $6.44 per share in cash for Chelsea's stock and issue contingent value rights worth up to $1.50 per share based on Northera sales between 2015 and 2017. But for Lundbeck and its…
written on 09.05.2014